DJ Biogen Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ rose 1.63% to $212.55 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.69% to 7,691.76 and Dow Jones Industrial Average falling 0.22% to 53,343.40.
The stock's rise snapped a two-day losing streak.
Biogen Inc. closed 3.26% below its 52-week high of $219.72, which the company achieved on June 29th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 3.33% to $271.11, Pfizer Inc. $(PFE)$ rose 1.41% to $27.25, and AbbVie Inc. $(ABBV)$ rose 3.43% to $258.92.
Trading volume (693,972) remained 538,064 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.